2023
PLOS Global Public Health, (2023).3 10 10.1371/journal.pgph.0002347.
2023
Wellcome Open Research, (2023).8, 10.12688/wellcomeopenres.19199.2.
IMMUNOGENICITY OF AN EXTENDED DOSE INTERVAL FOR THE AD26.ZEBOV, MVA-BN-FILO PROPHYLACTIC EBOLA VIRUS VACCINE REGIMEN IN ADULTS AND CHILDREN IN THE DEMOCRATIC REPUBLIC OF THE CONGO.
2023
ASTMH 2023 Annual Meeting Abstract Book (2023).
The effect of RTS,S/AS01E and SMC alone or combined on the acquisition of blood stage antimalarial antibody responses.
2023
(2023).
2023
Frontiers in immunology, (2023).14, 10.3389/fimmu.2023.1267372.
2023
PLOS global public health, (2023).3 10 10.1371/journal.pgph.0002427.
2023
Frontiers in nutrition, (2023).10, 10.3389/fnut.2023.1250002.
2023
Nature, (2023).623 7985 10.1038/s41586-023-06703-3.
2023
Nature, (2023).623 7985 10.1038/s41586-023-06695-0.
